Home › Pancreatic Cancer › NCT06595160

Determining the Link Between Dietary Patterns, Fecal Microbiome and Response to Neoadjuvant Chemotherapy

Determining the Link Between Dietary Patterns, Fecal Microbiome and Response to Neoadjuvant Chemotherapy in Pancreatic Ductal Adenocarcinoma Patients

Who can join

Ages 18 and older · All sexes

Inclusion Criteria:

* \* Age ≥ 18 years with signed informed consent form

  * Patients must have a histological diagnosis of PDAC
  * Resectable or borderline resectable PDAC on imaging

Exclusion Criteria:

* \* Patients with locally advanced and metastatic stage IV PDAC

  * Patients who have already received or completed neoadjuvant chemotherapy for PDAC
  * Patients with active malignancy receiving systemic therapy

About the study

This study explores the relationship between pre-treatment dietary patterns, fecal microbiome, and response to chemotherapy in patients with pancreatic ductal adenocarcinoma.

What is being tested

• Non-Interventional Study (other)

Sponsor: Emory University · Participants: 87 · Started: Aug 5, 2024

Contact the study team

• Mihir M. Shah, MD, FACS, FSSO · Phone: 404-778-3307

Official record on ClinicalTrials.gov — NCT06595160

Locations in the U.S.

Conditions

• Pancreatic Cancer

From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.